Summary
The paper proposes TimeWarn, an interpretable, time-aware attention model for early sepsis prediction from irregularly sampled EHR data. It extends the RETAIN architecture by introducing a learned exponential decay based on elapsed time between measurements, applied to both visit-level and variable-level attention. Evaluations on MIMIC-IV and eICU show consistent, modest improvements over strong baselines (GRU-D, RETAIN), along with ablations and attention analyses that align with clinical intuition.

Strengths
- Clear motivation: irregular sampling in EHRs and need for interpretability.
- Methodological contribution: simple, modular time decay applied to both attention levels.
- Empirical results: consistent gains across two large public ICU datasets with multiple seeds.
- Interpretability: attention highlights clinically meaningful variables (e.g., lactate, RR, MAP).
- Sensible ablation demonstrating that the time-decay mechanism drives part of the gains.
- Good clarity and organization, with limitations appropriately acknowledged.

Weaknesses and concerns
- Incremental novelty: time-aware mechanisms and decay for irregular EHRs have prior art (e.g., GRU-D; various time-aware attention/Transformer approaches). The main novelty is where/how decay is injected (both attention levels), which is modest.
- Fairness of comparisons: TimeWarn is tuned via grid search; baselines reportedly use original hyperparameters rather than retuned on this setup, which may disadvantage them.
- Method details need clarification:
  - How attention normalization interacts with decay (e.g., is decay applied before or after softmax, and are weights renormalized?).
  - Whether decay parameters are shared or per-variable (w, b vector vs scalar), and any constraints/regularization.
  - Handling of variables never previously measured within a window (Δ definition at sequence start) and any clipping of Δ.
  - Construction of window embeddings and treatment of missingness beyond a mask (e.g., imputation, carry-forward).
- Statistical testing: Mean±SD over five seeds is reported; adding paired significance tests would strengthen claims.
- Practical aspects: limited discussion of calibration, alert rates at clinically relevant thresholds, and runtime/efficiency compared with GRU-D/RETAIN.
- Scope: evaluation limited to ICU cohorts; generalizability to wards/out-of-ICU remains open.

Suggestions for improvement
- Provide clearer math/implementation details on attention scaling and normalization with decay, parameterization of w and b, and Δ initialization/clipping.
- Retune baselines on the same validation splits or add sensitivity analyses to address hyperparameter fairness.
- Include calibration (e.g., ECE, reliability plots), precision at fixed recall, and decision-curve or utility analysis to contextualize clinical utility.
- Consider comparisons with additional recent time-aware or self-/cross-attention baselines that incorporate relative/continuous time encodings.
- Report computational cost and inference latency.
- Add more thorough error analysis and subgroup performance (e.g., age, comorbidity, hospital site).

Scores (0–100)
- Soundness: 82
- Novelty: 70
- Significance: 75
- Clarity: 85

Final average score: 78.0

Recommendation: Accept
Rationale: Although the methodological novelty is incremental, the approach is well-motivated, simple, interpretable, and yields consistent improvements on two strong benchmarks with supporting ablations. The paper is clearly written and likely to be of interest to the clinical ML community. Addressing the noted fairness and methodological clarity points would further strengthen the work.